Inside information

LABORATORIOS FARMACEUTICOS ROVI, S.A.

• • 27/02/2024
  • 08:15
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On corporate governance
  • The Company informs about the agreements adopted by the Board of Directors.
  • Register number: 2126
• • 27/02/2024
  • 07:49
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the presentation related to the 2023 financial results
  • Register number: 2125
• • 27/02/2024
  • 07:48
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the press release related to the 2023 financial results
  • Register number: 2124
• • 08/11/2023
  • 15:33
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • Se remite de nuevo el comunicado de prensa a los solos efectos de corregir los conceptos de gastos de personal, otros gastos de explotación y trabajos efectuados por el grupo para activos no corrientes, manteniéndose el resto sin modificación alguna.
  • Register number: 2021
  • • Notification modified by communication number 2015 dated 08/11/2023 (07:35)
• • 08/11/2023
  • 07:37
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the presentation related to the first nine months of 2023 financial results
  • Register number: 2016
• • 08/11/2023
  • 07:35
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the press release related to the first nine months of 2023 financial results
  • Register number: 2015
  • • Notification modified by communication number 2021 dated 08/11/2023 (15:33)
• • 26/07/2023
  • 08:10
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the presentation related to the first half 2023 financial results
  • Register number: 1928
• • 26/07/2023
  • 08:10
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the press release related to the first half 2023 financial results
  • Register number: 1927
• • 26/07/2023
  • 08:09
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On share buy-back , stabilisation and treasury stock programmes
  • The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.
  • Register number: 1926
• • 10/05/2023
  • 07:40
  • LABORATORIOS FARMACEUTICOS ROVI, S.A.
  • On P&L
  • The Company releases the presentation related to the first quarter 2023 financial results
  • Register number: 1859